ABT-898

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameABT-898
Drug Alias Namethrombospondin-1 mimetic (Abbott)A-428898ABT-898
ClassificationSmall molecules > Peptidomimetic
Mechanisms of ActionApoptosis stimulantsPlatelet glycoprotein 4 stimulantsAngiogenesis inhibitors
TargetsPlatelet glycoprotein 4
Therapy Area/IndicationsOvarian NeoplasmsPolycystic Ovary Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAbbott Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbbott LaboratoriesAbbvie Inc
Active IndicationsN/A
Inactive IndicationsOvarian NeoplasmsPolycystic Ovary Syndrome

Other Information

ATC CodeN/A
Related LinksN/A